Evaluation of variability in care and outcomes for patients with gastrointestinal bleeding
消化道出血患者护理和结果变异性的评估
基本信息
- 批准号:9976091
- 负责人:
- 金额:$ 17.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAcuteAmerican Hospital AssociationAnticoagulationBedsCalibrationCaringCharacteristicsClinicalClinical PathwaysClinical Practice GuidelineDataData AnalyticsData SetDatabasesDevelopmentDevelopment PlansDiscriminationDiseaseEndoscopyEnrollmentEnsureEpidemiologyEvaluationFacultyFoundationsFundingGastrointestinal HemorrhageGoalsGrantHealth Care ReformHealth PolicyHealth Services ResearchHealth systemHeterogeneityHospitalizationHospitalsInpatientsInstitutionInterventional radiologyInterviewK-Series Research Career ProgramsLeadLearningLength of StayLinkMaster of ScienceMeasuresMedicareMedicare claimMentorsMentorshipMethodologyMethodsModelingNursesOutcomeOutcome MeasureOutpatientsPatient CarePatient-Focused OutcomesPatientsPharmacologic SubstancePhysiciansPlayPopulation HeterogeneityProceduresProcessProcess MeasureProviderQualitative MethodsResearchResearch PersonnelResourcesRiskRisk FactorsRoleScientistSourceStandardizationStatistical MethodsStructureSurveysTrainingUnited StatesUnited States National Institutes of HealthValidationVariantcare outcomescareer developmentclinical applicationcohortcomorbidityexperiencehospital performanceimprovedimproved outcomeinpatient servicemortalitymultilevel analysisnovelorganizational structurepatient populationreadmission ratesskillsstem
项目摘要
PROJECT SUMMARY
Gastrointestinal bleeding (GIB) is a major cause of inpatient hospitalizations in the United States, and
comprises a heterogeneous population with appreciable variability in patient outcomes amongst hospitals.
Nationally, 30-day mortality rates are estimated at 7%; however, mortality and readmission rates vary widely
across hospitals. Such variability suggests the potential to improve patient care and save lives by identifying
modifiable factors that influence outcomes after hospitalization with GIB. Patient-related factors, hospital
structure and processes of care play major roles in determining outcomes for many other diseases, but the
impact of these factors on outcomes related to GIB has not been adequately defined. The objective of this
proposal is to identify and understand sources of variation in care for patients with GIB, including patient-level
factors, organization (i.e. structure) and processes of care (e.g.. endoscopic and interventional radiology
utilization) amongst hospitals. Our central hypothesis is that modifiable factors impact patient outcomes during
hospitalizations for GIB, which include both structural characteristics and processes of care. Our proposal is to
build a multi-level model of patient outcomes standardized across hospitals, accounting for patient factors and
assess the impact of hospital factors, and then qualitatively explore additional processes of care, through the
following interrelated specific aims: Aim 1- To develop a risk-standardized model for GIB outcomes across
hospitals using Medicare inpatient, outpatient, and pharmaceutical claims data. To ensure generalizability and
clinical applicability, model validation will be performed in a multipayer, multicenter database and using UPenn
health system data which contains clinical variables. Aim 2 - to identify hospital factors (structures and
processes of care) associated with GIB outcomes, using a combined dataset of the aforementioned Medicare
data with American Hospital Association Annual Survey data. Aim 3 – to explore barriers and facilitators of
processes of care for inpatient GIB among hospitals with better and worse patient outcomes, using qualitative
methods. This mixed methods approach will allow for a comprehensive evaluation of drivers of variation in care
for gastrointestinal bleeding. The expected outcome for the proposed research is that it will identify important
modifiable factors in care associated with patient outcomes for those hospitalized with GIB. This can lead to
the development and validation of quality metrics to improve patient care. To facilitate completion of the
research and further the academic development of the applicant, the PI will enroll in coursework that builds on
her Master of Science by focusing on statistical methods using clustered and longitudinal data, data analytics
in confounding, and qualitative methodologies. This proposal has unequivocal and outstanding divisional and
institutional support and exceptional mentorship of experienced faculty with a strong track record in
epidemiology, health services research, and mentoring prior K-award grant recipients. These activities will
allow the PI to develop the skills necessary to become a successful independent NIH-funded investigator and a
leader in GI-related health services research.
项目摘要
胃肠道出血(GIB)是美国住院患者住院的主要原因,
包括医院之间患者结果具有明显差异的异质性人群。
在全国范围内,30天死亡率估计为7%;然而,死亡率和再入院率差异很大
跨医院这种变异性表明,通过识别和治疗,有可能改善患者护理和挽救生命。
影响GIB住院后结局的可改变因素。患者相关因素,医院
护理的结构和过程在决定许多其他疾病的结果方面发挥着重要作用,
这些因素对GIB相关结局的影响尚未充分确定。的目的
一项建议是确定和了解GIB患者护理的变化来源,包括患者水平
因素、组织(即结构)和护理过程(例如,内镜和介入放射学
(二)医院之间。我们的中心假设是,可改变的因素影响患者的结果,
GIB的住院治疗,其中包括结构特征和护理过程。我们的建议是
建立一个跨医院标准化的患者结局的多层次模型,考虑患者因素,
评估医院因素的影响,然后定性地探索额外的护理过程,通过
以下相互关联的具体目标:目标1-为GIB结果制定一个风险标准化模型,
医院使用医疗保险住院病人,门诊病人和药品索赔数据。为了确保普遍性,
临床适用性,将在多付款人、多中心数据库中使用UPenn进行模型验证
包含临床变量的卫生系统数据。目标2 -确定医院因素(结构和
使用上述医疗保险的组合数据集,
美国医院协会年度调查数据。目标3 -探讨促进发展的障碍和促进因素
采用定性分析方法,在患者结局较好和较差的医院中,
方法.这种混合方法的方法将允许全面评估护理变化的驱动因素
治疗消化道出血拟议研究的预期成果是,它将确定重要的
与GIB住院患者结局相关的护理中的可修改因素。这可能导致
质量指标的开发和验证,以改善患者护理。为协助完成
研究和进一步的申请人的学术发展,PI将参加课程,建立在
她的理学硕士,专注于使用聚类和纵向数据的统计方法,数据分析
和定性方法。这一建议具有明确和突出的分工和
机构的支持和经验丰富的教师的特殊指导,具有良好的记录,在
流行病学,卫生服务研究,并指导以前的K奖补助金获得者。这些活动将
允许PI发展成为成功的独立NIH资助的研究者和
GI相关健康服务研究的领导者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shazia Mehmood Siddique其他文献
Spotlight: Management of Moderate-to-Severe Ulcerative Colitis
- DOI:
10.1053/j.gastro.2020.03.012 - 发表时间:
2020-04-01 - 期刊:
- 影响因子:
- 作者:
Joseph D. Feuerstein;Kim L. Isaacs;Yecheskel Schneider;Shazia Mehmood Siddique;Yngve Falck-Ytter;Siddharth Singh; American Gastroenterological Association Institute Clinical Guidelines Committee - 通讯作者:
American Gastroenterological Association Institute Clinical Guidelines Committee
AGA Living Clinical Practice Guideline on Computer-Aided Detection–Assisted Colonoscopy
AGA 生活临床实践指南:计算机辅助检测辅助结肠镜检查
- DOI:
10.1053/j.gastro.2025.01.002 - 发表时间:
2025-04-01 - 期刊:
- 影响因子:25.100
- 作者:
Shahnaz Sultan;Dennis L. Shung;Jennifer M. Kolb;Farid Foroutan;Cesare Hassan;Charles J. Kahi;Peter S. Liang;Theodore R. Levin;Shazia Mehmood Siddique;Benjamin Lebwohl - 通讯作者:
Benjamin Lebwohl
Shazia Mehmood Siddique的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shazia Mehmood Siddique', 18)}}的其他基金
Evaluation of variability in care and outcomes for patients with gastrointestinal bleeding
消化道出血患者护理和结果变异性的评估
- 批准号:
10388264 - 财政年份:2020
- 资助金额:
$ 17.14万 - 项目类别:
Evaluation of variability in care and outcomes for patients with gastrointestinal bleeding
消化道出血患者护理和结果变异性的评估
- 批准号:
10598129 - 财政年份:2020
- 资助金额:
$ 17.14万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 17.14万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 17.14万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 17.14万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 17.14万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 17.14万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 17.14万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 17.14万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 17.14万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 17.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
Operating Grants